Alchem International expands India facility

Alchem International expands India facility

Fully automated facility has a production capacity of more than 75 metric tons of Sennosides USP per year.

Alchem International Ltd. announces the inauguration of its expanded Neemrana, India, facility dedicated exclusively to the production of Sennosides USP. Sennosides, extracted from senna leaves and pods, are used as laxatives in traditional and modern medicine preparations.

“Expansion of our facility was necessary to answer the growing demand for 60 percent USP Sennosides. The fully automated facility has a production capacity of more than 75 metric tons per year,” states Raman Mehta, president of Alchem International Ltd. “Alchem’s facility also incorporates a state-of-the-art laboratory control able to test USP monographs and to support our customers with Drug Master File requirements.”

The company applies a fully integrated production process, from cultivating its own senna leaves and pods to producing its own energy from the byproducts of its Sennoside extraction. Alchem’s facility is GMP-certified and regularly audited by international customers as well as officials such as the U.S. Food and Drug Administration.

“With our long-time North American distributor, Ampak Co. in New York, and our recently opened U.S. liaison office, we’re able to better serve our North American customers by offering local inventory of 60 percent USP Sennosides and technical support,” added Mehta.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.